SPK Acquisition Corp. announced that it has entered into a subscription agreement with Alpha Capital AG, and Varian Biopharmaceuticals Inc. to issue unsecured promissory notes worth $50,000 to each for gross proceeds of $100,000 on September 8, 2022. The note bears 5% interest per annum and is repayable at the earlier of consummation of the company’s initial business combination or a default unless due earlier.

As of the same date, the company has received $50,000 from Alpha Capital AG in its first tranche. The note issued to Varian Biopharmaceuticals Inc. may be terminated if the merger closes on or before October 8, 2022.